Immune response after ChAdOx1 nCoV-19 Vaccine in kidney transplant patients compared to healthy volunteers. Immune response, ChAdOx1 nCoV-19 Vaccine, kidney transplant patients, Wuhan Strain, B.1.617.2 (Delta) Variant, antibody, T-cell response
Conditions
Interventions
Kidney transplant patients who received 2 doses of ChAdOx1 nCoV-19 Vaccine,Healthy volunteers who received 2 doses of ChAdOx1 nCoV-19 Vaccine
Prevention,Prevention
Kidney transplant patients,Healthy volunteers
Sponsors
Kao Tun Roke Foundation
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Adult (age >= 18 years old), 2.Kidney transplant recipients, 3. Recipients 2 doses of ChAdOx1 nCoV-19 vaccine
Exclusion criteria
Exclusion criteria: 1. Refuse to participate, 2.Infected with COVID-19 during the study period, 3. Recipients of intravenous immunoglobulin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunogenicity 2-6 weeks after vaccination Antibody response and T-cell response | — |
Secondary
| Measure | Time frame |
|---|---|
| Associated factors of antibody response After the results of immune response Statistical analysis,Associated factors of T-cell response After the results of immune response Statistical analysis,Safety and adverse reactions after vaccination After completion of each dose of vaccination Statistical analysis | — |
Countries
Thailand
Contacts
Public ContactSiriorn Watcharananan
Praram 9 Hospital
Outcome results
None listed